Page last updated: 2024-08-23

phenyl acetate and Angina, Unstable

phenyl acetate has been researched along with Angina, Unstable in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (53.85)18.2507
2000's4 (30.77)29.6817
2010's2 (15.38)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kastelein, JJP; Lincoff, AM; Mani, P; Menon, V; Nicholls, SJ; Nissen, SE; Puri, R; Schwartz, GG; Shao, M1
Bash, D; Brennan, DM; Cavender, MA; Jukema, JW; Kastelein, JJ; Koenig, W; Lincoff, AM; Menon, V; Nambi, V; Nicholls, SJ; Nissen, SE; Rosenson, RS; Schwartz, GG; Wright, RS1
Bokslag, M; Boudreault, JR; Delage, F; Diodati, JG; Dupuis, R; Fung, AY; Kells, C; Knudtson, ML; Kouz, S; Marquis, JF; Nasmith, J; Rapold, HJ; Roy, L; Steiner, B; Théroux, P1
Gawaz, M; Neumann, FJ; Schömig, A1
Moliterno, DJ; Steinhubl, SR1
Adgey, AA1
Armstrong, PW; Braunwald, E; Califf, RM; Gibler, WB; Hamm, CW; Maseri, A; Simoons, ML; Van de Werf, F1
Phillips, J; Stouffer, GA; Subbarao, VD1
White, HD1
Bachmann, LM; Golder, S; Kleijnen, J; McDonagh, MS; ter Riet, G1
Berkowitz, SD1
SoRelle, R1

Reviews

8 review(s) available for phenyl acetate and Angina, Unstable

ArticleYear
[Platelet membrane glycoproteins as site of pharmacological intervention in the treatment of coronary disease].
    Deutsche medizinische Wochenschrift (1946), 1997, Oct-02, Volume: 122, Issue:40

    Topics: Abciximab; Acetates; Alkynes; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Benzamidines; Binding Sites; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Coronary Disease; Double-Blind Method; Eptifibatide; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Platelet Membrane Glycoproteins; Randomized Controlled Trials as Topic; Receptors, Antigen, B-Cell; Receptors, Cell Surface; Time Factors; Tirofiban; Tyrosine

1997
Glycoprotein IIb/IIIa receptor antagonists for the treatment of unstable angina.
    Heart and vessels, 1997, Volume: Suppl 12

    Topics: Abciximab; Acetates; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Clinical Trials as Topic; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Ischemia; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recurrence; Tirofiban; Treatment Outcome; Tyrosine

1997
An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.
    European heart journal, 1998, Volume: 19 Suppl D

    Topics: Abciximab; Acetates; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Atherectomy, Coronary; Coronary Disease; Eptifibatide; Fibrinolytic Agents; Heparin; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Myocardial Ischemia; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Survival Analysis; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine

1998
Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes.
    European heart journal, 1998, Volume: 19 Suppl D

    Topics: Abciximab; Acetates; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Disease; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine

1998
Use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease.
    The American journal of the medical sciences, 1999, Volume: 318, Issue:2

    Topics: Abciximab; Acetates; Acute Disease; Administration, Oral; Angina, Unstable; Antibodies, Monoclonal; Clinical Trials as Topic; Coronary Disease; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Infusions, Intravenous; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine

1999
Low-molecular-weight heparin and platelet glycoprotein IIb/IIIa receptor blockade in the treatment of acute coronary syndromes: complementary or competing therapies?
    The Journal of invasive cardiology, 2000, Volume: 12 Suppl A

    Topics: Acetates; Angina, Unstable; Anticoagulants; Confidence Intervals; Controlled Clinical Trials as Topic; Enoxaparin; Female; Humans; Male; Myocardial Infarction; Odds Ratio; Platelet Aggregation Inhibitors; Survival Rate; Treatment Outcome; Tyrosine

2000
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of glycoprotein IIb/IIIa antagonists in the medical management of unstable angina.
    Health technology assessment (Winchester, England), 2000, Volume: 4, Issue:30

    Topics: Acetates; Angina, Unstable; Biphenyl Compounds; Cost-Benefit Analysis; Eptifibatide; Female; Humans; Male; Oximes; Peptides; Piperidines; Platelet Aggregation Inhibitors; Pyrrolidines; Tirofiban; Tyrosine

2000
Current knowledge of the platelet glycoprotein IIb/IIIa receptor antagonists for the treatment of coronary artery disease.
    Haemostasis, 2000, Volume: 30 Suppl 3

    Topics: Abciximab; Acetates; Angina, Unstable; Angioplasty, Balloon, Coronary; Animals; Antibodies, Monoclonal; Coronary Artery Bypass; Coronary Disease; Drug Approval; Eptifibatide; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Mice; Multicenter Studies as Topic; Myocardial Ischemia; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Recombinant Fusion Proteins; Recurrence; Safety; Single-Blind Method; Stents; Survival Analysis; Tirofiban; Treatment Outcome; Tyrosine; United States; United States Food and Drug Administration

2000

Trials

4 trial(s) available for phenyl acetate and Angina, Unstable

ArticleYear
Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial.
    JAMA cardiology, 2019, 04-01, Volume: 4, Issue:4

    Topics: Acetates; Acute Coronary Syndrome; Aged; Angina, Unstable; Australia; C-Reactive Protein; Death; Europe; Female; Humans; India; Indoles; Keto Acids; Male; Middle Aged; Myocardial Infarction; New Zealand; North America; Phospholipase A2 Inhibitors; Placebos; Risk Factors; Stroke; Treatment Outcome

2019
Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial.
    JAMA, 2014, Jan-15, Volume: 311, Issue:3

    Topics: Acetates; Acute Coronary Syndrome; Aged; Angina, Unstable; Atherosclerosis; Atorvastatin; Double-Blind Method; Early Termination of Clinical Trials; Female; Heptanoic Acids; Humans; Indoles; Keto Acids; Male; Middle Aged; Myocardial Infarction; Phospholipases A; Phospholipases A2, Secretory; Pyrroles; Risk; Stroke; Survival Analysis; Treatment Outcome

2014
Platelet membrane receptor glycoprotein IIb/IIIa antagonism in unstable angina. The Canadian Lamifiban Study.
    Circulation, 1996, Sep-01, Volume: 94, Issue:5

    Topics: Acetates; Adult; Aged; Angina, Unstable; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Tyrosine

1996
International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. The PARAGON Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Gl
    Circulation, 1998, Jun-23, Volume: 97, Issue:24

    Topics: Acetates; Aged; Angina, Unstable; Anticoagulants; Aspirin; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Survival Analysis; Tyrosine

1998

Other Studies

1 other study(ies) available for phenyl acetate and Angina, Unstable

ArticleYear
Platelet glycoprotein IIb/IIIa inhibitor effect examined in 2 studies.
    Circulation, 2002, Jan-22, Volume: 105, Issue:3

    Topics: Acetates; Acute Disease; Angina, Unstable; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Eptifibatide; Humans; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prognosis; Syndrome; Treatment Outcome; Tyrosine

2002